IRAQI JOURNAL OF HEMATOLOGY : Impact Factor & More
eISSN: 2543-2702pISSN: 2072-8069
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on IRAQI JOURNAL OF HEMATOLOGY
IRAQI JOURNAL OF HEMATOLOGY Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ
| Overview | |
| Publisher | WOLTERS KLUWER MEDKNOW PUBLICATIONS |
| Language | English |
| Frequency | Semi-annual |
| Publication Time | 17 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | The National Center of Hematology/ Almustansiriya University |
| Frequency | Semi-annual |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Other charges | Visit website |
| Publication Time | 17 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC-SA |
| OA statement | Visit website |
View less
Planning to publish in IRAQI JOURNAL OF HEMATOLOGY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in IRAQI JOURNAL OF HEMATOLOGY
Assessment of fragile histidine triad (FHIT) gene expression as a predictive biomarker of therapeutic response in chronic myeloid leukemia
- 21 Mar 2026
- Iraqi Journal of Hematology
Assessment of the immunomodulatory cytokines interleukin-35, interleukin-10, and transforming growth factor-β in patients with idiopathic immune thrombocytopenia purpura on treatment with romiplostim: A cross-sectional analysis
- 21 Mar 2026
- Iraqi Journal of Hematology
Minimizing the risk of acquisition of infections among pregnant women with sickle cell disease
- 21 Mar 2026
- Iraqi Journal of Hematology
Decoding hereditary spherocytosis: Unveiling the genes as a potential causative agent
- 7 Feb 2026
- Iraqi Journal of Hematology
Real-world experience with romiplostim in the management of primary immune thrombocytopenia in Iraqi adult patients
- 7 Feb 2026
- Iraqi Journal of Hematology
Transforming hemophilia registries into tools for health equity in low- and middle-income countries: From counting patients to changing care
- 7 Feb 2026
- Iraqi Journal of Hematology
Assessment of fragile histidine triad (FHIT) gene expression as a predictive biomarker of therapeutic response in chronic myeloid leukemia
- 21 Mar 2026
- Iraqi Journal of Hematology
Assessment of the immunomodulatory cytokines interleukin-35, interleukin-10, and transforming growth factor-β in patients with idiopathic immune thrombocytopenia purpura on treatment with romiplostim: A cross-sectional analysis
- 21 Mar 2026
- Iraqi Journal of Hematology
Minimizing the risk of acquisition of infections among pregnant women with sickle cell disease
- 21 Mar 2026
- Iraqi Journal of Hematology
Decoding hereditary spherocytosis: Unveiling the genes as a potential causative agent
- 7 Feb 2026
- Iraqi Journal of Hematology
Real-world experience with romiplostim in the management of primary immune thrombocytopenia in Iraqi adult patients
- 7 Feb 2026
- Iraqi Journal of Hematology
Transforming hemophilia registries into tools for health equity in low- and middle-income countries: From counting patients to changing care
- 7 Feb 2026
- Iraqi Journal of Hematology
FAQs on IRAQI JOURNAL OF HEMATOLOGY
How long has IRAQI JOURNAL OF HEMATOLOGY been actively publishing? 
What is the publishing frequency of IRAQI JOURNAL OF HEMATOLOGY?
How many articles did IRAQI JOURNAL OF HEMATOLOGY publish last year?
What is the eISSN & pISSN for IRAQI JOURNAL OF HEMATOLOGY?
Who is the publisher of IRAQI JOURNAL OF HEMATOLOGY?
